Generics 185

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Desloratadine manufacturers

185 products found

Filters

185 products found

desloratadine

Tablets 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21631

Manufacturer usually replies in 5 days

desloratadine

Syrup 0.5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21631

Manufacturer usually replies in 5 days

desloratadine

Tablets 5mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , United Kingdom , Vietnam , Iraq
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

desloratadine

Oral solution 500mcg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Germany , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

desloratadine

Oral solution 0.5 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Registered in
Portugal
Available for
Licensing with supply, Distribution only
Manufacturer #1377
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, North America, Africa, and Asia for 200+ years. Key production lines are Rx, OTC, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. Main dosage forms include solids, liquids, semi-solids, and sterile forms.

Manufacturer usually replies in 8 days

desloratadine

Tablets, film coated 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
MAs for sale
Spain
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

desloratadine

Tablets 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #20828
It is a pharmaceutical firm dedicated to improving the health and quality of human life. And what the corporation can manufacture and refine to match consumer demands. The company was established in the 1980s. Since then it has been in business for 25 years.

Manufacturer usually replies in 7 days

desloratadine

Oral suspension 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Spain
Manufacturer #10578

Manufacturer usually replies in 6 days

desloratadine

Tablets, film coated 5mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

desloratadine

Syrup 2,5mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

desloratadine

Tablets 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070
A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

desloratadine

Syrup 0.5 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070
A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

desloratadine

Oral solution 0.5 mg/ml - 120 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Bulgaria , Turkmenistan
Available for
Licensing with supply
Manufacturer #15813
A pharmaceutically oriented holding company that provides pharmacological solutions like never before. Their core business line entails dealing with the development, manufacturing, and distribution of pharmaceutical products, food supplements as well as cosmetics too.

Manufacturer usually replies in 12 days

desloratadine

Tablets, film coated 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

desloratadine

Tablets, orally disintegrating (ODT) 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

desloratadine

Oral solution 0.5 mg/ml - 60 ml, 120 ml, 150 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

desloratadine

Oral solution 0.5 mg/ml - 150 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #688
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years. Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders. The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture. Regularity team prepares EU CTD format document.

Manufacturer usually replies in 16 days

desloratadine

Tablets 5mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Czech Republic , Germany , Netherlands , Poland , Romania , Slovakia , Spain , United Kingdom , Iraq
Manufacturer #6978

Manufacturer usually replies in 3 days

desloratadine

Oral solution 0.5 g/ml - 60 ml, 150 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #279

Manufacturer usually replies in nan days

desloratadine

Tablets, film coated 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
RX
Manufacturer #279

Manufacturer usually replies in nan days

Want to view all 185 products? Create your free account today!

Desloratadine

Desloratadine is a medication called antihistamine. Desloratadine is used to treat hay fever and allergy symptoms, including sneezing; runny nose; and red, itchy, tearing eyes in adults and children to relieve. It is also used to relieve symptoms of hives, the red, itchy raised areas of the skin, including itches and rashes. antihistamine works by blocking histamine, a substance in the body that causes allergic symptoms. Desloratadine is sold under the trade names Clarinex and Aerius to name a few. It was patented in 1984 and came into medical use in 2001. Merck Sharp Dohme makes Clarinex, a brand name of desloratadine, approved by the FDA in 2004. In the European union, the patent is held by Cipla limited, several other companies like TARO, Dr, Reddy’s also got approvals to launch their version of this product in other countries.

Forms and dose

Desloratadine comes as a tablet, oral solution (liquid), and an orally disintegrating tablet to take by mouth. It is taken once a day with or without food. The Usual Adult Dose for Allergic Rhinitis is 5 mg orally, once a day and for Urticaria too it is 5 mg orally once a day. In the treatment of Allergic Rhinitis, Usual Pediatric Dose for 6 to 11 months babies is 1 mg orally once a day and for kids aged 12 months to 5 years, it is 1.25 mg orally once a day. For growing kids between 6 to 11 years, the dose is 2.5 mg orally once a day and for kids older than 12 years and older, it is 5 mg orally once a day. The Usual Pediatric Dose for Urticaria for children age 6 to 11 months is 1 mg orally once a day, for kids 12 months to 5 years, the dose is 1.25 mg orally once a day. For kids between 6 to 11 years, it is 2.5 mg orally once a day and for kids 12 years and older the dose is 5 mg orally once a day.

The price of Desloratadine

In the USA, the consumers have to pay an average retail price of $112.22 for a supply of 30 tablets of 5mg strength. In the UK, the same supply costs significantly less at 45 pounds.

How does Desloratadine work

Desloratadine blocks a type of receptor for H1 and thus prevents activation of cells by histamine. Unlike other antihistamines, it does not enter the brain from the blood and, thus, does not cause drowsiness. Desloratadine’s actions block a certain natural substance (histamine) that your body makes during an allergic reaction.

Finding Desloratadine Manufacturers and Desloratadine Suppliers

One of the fastest and easiest ways to find Desloratadine manufacturers and Desloratadine suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Usually, finding trusted manufacturers and supplies of specific drugs like Desloratadine can be a time- consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Desloratadine to work with. You can fine-tune your search results using various filters too, letting you search for Desloratadine from specific countries, for example.